A new cancer drug has been announced by Cancer Therapeutics CRC in Melbourne. CTx-294886 is to be used in conjunction with another medication, Avastin. Furthermore, a new type of scanning has been developed by the same company. It will identify protein homeostasis, a new pathway in cancer treatment. CTx-0294886 stops tumour growth by inhibiting Focal Adhesion Kinase (FAK) and Vascular Endothelial Growth Factor Receptor 3 (VEGFR3). This with Avastin reduces angiogenesis, slowing tumor growth in breast cancer. Examination of effects in head, neck and cervical cancers is ongoing. The company has already developed a primary anti-cancer medication, CTx-294945). Both drugs can now be used to prolong life when dancer is detected. Research was done with the assistance of Australian and international institutions. http://www.adventure--australia.blogspot.com/ http://www.tysaustralia.blogspot.com/ http://www.feeds.feedburner.com/AdventureAustralia http://www.technorati.com/blogs/ htt...
Interesting articles, stories, news. Views on happenings. Current activities, ideas and events. International and Antipodean affairs - scientific, cultural, political, economic, sociological, anthropological, archaeological and historical environment.🤠By TyBuchanan